65,437 trials
Cancer
Primary: Incidence of Success (Achieving an End Infusion Peripheral Blood Methotrexate Concentration Between 50-80 μM) — 57 uM — p=<0.01
Crohn Disease
Primary: Number of Patients in Remission at Week 16 — 3; 14 Participants
Healthy Volunteers
Primary: Cmax: Maximum Observed Serum Concentration — 86100; 81100; 87500 (ng/mL)/(mg/mL)
Hypertension
Primary: Blood Pressure Knowledge Questionnaire — 6.13 score on a scale
Schizophrenia
Primary: Change From Baseline in Cognitive Function as Measured by the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive…
Carpal Tunnel Syndrome
Primary: Functional Status Scale of the Boston Carpal Tunnel Syndrome Questionnaire — 1.6; 1.8 units on a scale
Parkinson Disease
Primary: Changes in Gait Velocity — 1.10; 1.15 m/s
Heart Failure
Primary: Self-care Maintenance in Patients — 52.36; 54.23; 49.63 score on a scale
Recurrent Miscarriage · Spontaneous Abortion · Mannose-Binding Lectin Deficiency
Primary: Plasma MBL Level (ug/ml) — 717; 1717 ug/l — p=<0.001
Carcinoma, Non-Small-Cell Lung
Primary: Percentage of Participants With Adverse Drug Reactions (ADRs) — 89.92 Percentage of participants
Chronic Obstructive Pulmonary Disease
Primary: Change in Number of Daily Steps Between the Intervention and Control Conditions — -344.8; -975.8 steps
Stroke, Ischemic
Primary: Attendance Rate — 8 Participants
Infection With Multi-drug Resistant Organisms
Primary: Safety of FMT in Patients With Recurrent MDRO Infections (Incidence and Severity of Solicited and Serious Adverse Events) — 0; 1 Participants
Emotions
Primary: The Ability to Perceive Negative and Positive Emotional Expressions, as Measured by a Behavioral Computer-based Assessment — 77.31; 81.93; 84.85 Percent of correct…
Hemorrhage · Cesarean Section
Primary: Pearson Correlation Coefficient for Hemoglobin Measurements — 0.6 Correlation Coeficient